Pnc Financial Services Group, Inc. Precigen, Inc. Transaction History

Pnc Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$1.41 - $2.79 $38 - $75	27 New	27 $0
Q4 2021 Feb 11, 2022	SELL	$3.53 - $5.5 $228,969 - $356,752	-64,864 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$4.99 - $6.55 $73,617 - $96,632	-14,753 Reduced 18.53%	64,864 $323,000
Q2 2021 Aug 06, 2021	BUY	$6.24 - $8.22 $186,657 - $245,884	29,913 Added 60.18%	79,617 $519,000
Q1 2021 May 07, 2021	SELL	$6.74 - $10.95 $20 - $32	-3 Reduced 0.01%	49,704 $342,000
Q4 2020 Feb 12, 2021	SELL	$3.75 - $10.56 $386,351 - $1.09 Million	-103,027 Reduced 67.46%	49,707 $507,000
Q1 2020 May 08, 2020	BUY	$1.46 - $7.19 $222,991 - $1.1 Million	152,734 New	152,734 $519,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $187M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.